164 related articles for article (PubMed ID: 34193977)
1. Germline POT1 variants can predispose to myeloid and lymphoid neoplasms.
Lim TL; Lieberman DB; Davis AR; Loren AW; Hausler R; Bigdeli A; Li Y; Powers J; Raper A; Regeneron Genetics Center ; Carty SA; Nathanson KL; Bagg A; Hexner EO; Maxwell KN; Morrissette JJD; Babushok DV
Leukemia; 2022 Jan; 36(1):283-287. PubMed ID: 34193977
[No Abstract] [Full Text] [Related]
2. Germline POT1 Deregulation Can Predispose to Myeloid Malignancies in Childhood.
Michler P; Schedel A; Witschas M; Friedrich UA; Wagener R; Mehtonen J; Brozou T; Menzel M; Walter C; Nabi D; Pearce G; Erlacher M; Göhring G; Dugas M; Heinäniemi M; Borkhardt A; Stölzel F; Hauer J; Auer F
Int J Mol Sci; 2021 Oct; 22(21):. PubMed ID: 34769003
[TBL] [Abstract][Full Text] [Related]
3. Germline mutations in shelterin complex genes are associated with familial glioma.
Bainbridge MN; Armstrong GN; Gramatges MM; Bertuch AA; Jhangiani SN; Doddapaneni H; Lewis L; Tombrello J; Tsavachidis S; Liu Y; Jalali A; Plon SE; Lau CC; Parsons DW; Claus EB; Barnholtz-Sloan J; Il'yasova D; Schildkraut J; Ali-Osman F; Sadetzki S; Johansen C; Houlston RS; Jenkins RB; Lachance D; Olson SH; Bernstein JL; Merrell RT; Wrensch MR; Walsh KM; Davis FG; Lai R; Shete S; Aldape K; Amos CI; Thompson PA; Muzny DM; Gibbs RA; Melin BS; Bondy ML;
J Natl Cancer Inst; 2015 Jan; 107(1):384. PubMed ID: 25482530
[TBL] [Abstract][Full Text] [Related]
4. Telomere-lengthening germline variants predispose to a syndromic papillary thyroid cancer subtype.
DeBoy EA; Nicosia AM; Liyanarachchi S; Iyer SS; Shah MH; Ringel MD; Brock P; Armanios M
Am J Hum Genet; 2024 Jun; 111(6):1114-1124. PubMed ID: 38688277
[TBL] [Abstract][Full Text] [Related]
5. A new POT1 germline mutation-expanding the spectrum of POT1-associated cancers.
Wilson TL; Hattangady N; Lerario AM; Williams C; Koeppe E; Quinonez S; Osborne J; Cha KB; Else T
Fam Cancer; 2017 Oct; 16(4):561-566. PubMed ID: 28389767
[TBL] [Abstract][Full Text] [Related]
6. Nonsense mutations in the shelterin complex genes ACD and TERF2IP in familial melanoma.
Aoude LG; Pritchard AL; Robles-Espinoza CD; Wadt K; Harland M; Choi J; Gartside M; Quesada V; Johansson P; Palmer JM; Ramsay AJ; Zhang X; Jones K; Symmons J; Holland EA; Schmid H; Bonazzi V; Woods S; Dutton-Regester K; Stark MS; Snowden H; van Doorn R; Montgomery GW; Martin NG; Keane TM; López-Otín C; Gerdes AM; Olsson H; Ingvar C; Borg A; Gruis NA; Trent JM; Jönsson G; Bishop DT; Mann GJ; Newton-Bishop JA; Brown KM; Adams DJ; Hayward NK
J Natl Cancer Inst; 2015 Feb; 107(2):. PubMed ID: 25505254
[TBL] [Abstract][Full Text] [Related]
7. The enigma of excessively long telomeres in cancer: lessons learned from rare human POT1 variants.
Gong Y; Stock AJ; Liu Y
Curr Opin Genet Dev; 2020 Feb; 60():48-55. PubMed ID: 32155570
[TBL] [Abstract][Full Text] [Related]
8. Association of the POT1 Germline Missense Variant p.I78T With Familial Melanoma.
Wong K; Robles-Espinoza CD; Rodriguez D; Rudat SS; Puig S; Potrony M; Wong CC; Hewinson J; Aguilera P; Puig-Butille JA; Bressac-de Paillerets B; Zattara H; van der Weyden L; Fletcher CDM; Brenn T; Arends MJ; Quesada V; Newton-Bishop JA; Lopez-Otin C; Bishop DT; Harms PW; Johnson TM; Durham AB; Lombard DB; Adams DJ
JAMA Dermatol; 2019 May; 155(5):604-609. PubMed ID: 30586141
[TBL] [Abstract][Full Text] [Related]
9. Somatic reversion impacts myelodysplastic syndromes and acute myeloid leukemia evolution in the short telomere disorders.
Schratz KE; Gaysinskaya V; Cosner ZL; DeBoy EA; Xiang Z; Kasch-Semenza L; Florea L; Shah PD; Armanios M
J Clin Invest; 2021 Sep; 131(18):. PubMed ID: 34343137
[TBL] [Abstract][Full Text] [Related]
10. A rare missense variant in protection of telomeres 1 (POT1) predisposes to a range of haematological malignancies.
Nathan V; Johansson PA; Palmer JM; Hamilton HR; Howlie M; Brooks KM; Hayward NK; Pritchard AL
Br J Haematol; 2021 Jan; 192(2):e57-e60. PubMed ID: 33216348
[No Abstract] [Full Text] [Related]
11. Identification of a Cancer-Predisposing Germline
Jajosky AN; Mitchell AL; Akgul M; Shetty S; Yoest JM; Gerson SL; Sadri N; Oduro KA
Genes (Basel); 2022 Mar; 13(4):. PubMed ID: 35456397
[TBL] [Abstract][Full Text] [Related]
12. Germline POT1 mutation and neuroblastoma: A mere coincidence or true association.
Legrand C; Peysselon M; Bidart M; Bouras A
Pediatr Blood Cancer; 2024 Jul; 71(7):e31054. PubMed ID: 38706191
[No Abstract] [Full Text] [Related]
13. A new mutant at the end: TPP1, telomeres, and BMF.
Bertuch AA
Blood; 2014 Oct; 124(18):2757-8. PubMed ID: 25359981
[No Abstract] [Full Text] [Related]
14. Targeted gene panels identify a high frequency of pathogenic germline variants in patients diagnosed with a hematological malignancy and at least one other independent cancer.
Singhal D; Hahn CN; Feurstein S; Wee LYA; Moma L; Kutyna MM; Chhetri R; Eshraghi L; Schreiber AW; Feng J; Wang PP; Babic M; Parker WT; Gao S; Moore S; Das S; Thomas D; Pattnaik S; Brown AL; D'Andrea RJ; Poplawski NK; Thomas D; Scott HS; Godley LA; Hiwase DK
Leukemia; 2021 Nov; 35(11):3245-3256. PubMed ID: 33850299
[TBL] [Abstract][Full Text] [Related]
15. Myeloid Neoplasm With Germline Predisposition: A 2016 Update for Pathologists.
Gao J; Gong S; Chen YH
Arch Pathol Lab Med; 2019 Jan; 143(1):13-22. PubMed ID: 29372845
[TBL] [Abstract][Full Text] [Related]
16. Molecular Pathology: Prognostic and Diagnostic Genomic Markers for Myeloid Neoplasms.
Kuo FC
Surg Pathol Clin; 2016 Sep; 9(3):475-88. PubMed ID: 27523973
[TBL] [Abstract][Full Text] [Related]
17.
Shen E; Xiu J; Lopez GY; Bentley R; Jalali A; Heimberger AB; Bainbridge MN; Bondy ML; Walsh KM
J Med Genet; 2020 Oct; 57(10):664-670. PubMed ID: 31937561
[TBL] [Abstract][Full Text] [Related]
18. Familial Clonal Hematopoiesis in a Long Telomere Syndrome.
DeBoy EA; Tassia MG; Schratz KE; Yan SM; Cosner ZL; McNally EJ; Gable DL; Xiang Z; Lombard DB; Antonarakis ES; Gocke CD; McCoy RC; Armanios M
N Engl J Med; 2023 Jun; 388(26):2422-2433. PubMed ID: 37140166
[TBL] [Abstract][Full Text] [Related]
19. Frequency of pathogenic/likely pathogenic germline variants in cancer-related genes among children with acute leukemia in Saudi Arabia.
Alsultan A; Essa M; Aljefri A; Ayas M; Alharbi M; Alkhayat N; Al-Anzi F; Yassin F; Alkasim F; Alharbi Q; Abdullah S; Jastaniah W
Pediatr Blood Cancer; 2020 Jul; 67(7):e28340. PubMed ID: 32359129
[TBL] [Abstract][Full Text] [Related]
20. Loss-of-function variants in
Nathan V; Palmer JM; Johansson PA; Hamilton HR; Warrier SK; Glasson W; McGrath LA; Kahl VFS; Vasireddy RS; Pickett HA; Brooks KM; Pritchard AL; Hayward NK
J Med Genet; 2021 Apr; 58(4):234-236. PubMed ID: 32907878
[No Abstract] [Full Text] [Related]
[Next] [New Search]